Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Uterine Cervical Dysplasia 3 Glioma 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Ependymoma 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1

Interventions

Nivolumab 11 pembrolizumab 10 Ipilimumab 9 Cyclophosphamide 6 tebentafusp 5 Interleukin-2 4 Blood Specimen Collection 4 fludarabine phosphate 3 fludarabine 3 Specimen Handling 3 Radiosurgery 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 relatlimab 2 lenvatinib 2 cemiplimab 2 binimetinib 2 aflibercept 2 Surveys and Questionnaires 2 Dacarbazine 2 Crizotinib 2 Carmustine 2 Biopsy 2 ulixertinib 1 trametinib 1 sargramostim 1 ruxolitinib 1 omipalisib 1 olaparib 1 lifileucel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Watchful Waiting × 1 year × Clear all

NCT07338968 2026-01-14

CoMpass

Aura Biosciences

Not yet recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡